People · Operator
Named in public records as an officer, director or promoter · active 2014–2015 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Idun Pharmaceuticals Inc | — | Pharmaceuticals | Seed | $3.9M | $42.8M | 2014 |
James O. Scopa at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James O. Scopa on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David F Hale | 1 | 16 |
| Paul F. Klingenstein | 1 | 2 |
| Shahzad F. Malik | 1 | 2 |
| Louis F. Lacasse | 1 | 2 |
| STEVEN J. MENTO, PH.D. | 1 | 2 |
| WILLIAM F. GERBER, M.D. | 1 | 2 |
| Harold O. Van Wart, Ph.D. | 1 | 1 |
| Marc O. Perret | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.